Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Inhaled GSK961081 in Healthy Subjects and COPD Patients
NCT00478738Phase 2Completed
- Sponsor
- GSK
- Start
- Jun 2007
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of batefenterol in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Jun 2007; status: completed.
02
Drugs
batefenterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00478738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00478738.